Trials / Completed
CompletedNCT01454050
Lumax 740 Master Study
PME/Master Study of the Lumax 740 ICD Family
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 189 (actual)
- Sponsor
- Biotronik SE & Co. KG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to prove the safety and efficacy of the Lumax 740 ICD family. Primarily, the newly implemented RV/LV Capture Control algorithm is evaluated, which automatically measures the RV/LV threshold and subsequently adjusts the pacing output.
Conditions
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2011-10-18
- Last updated
- 2012-11-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01454050. Inclusion in this directory is not an endorsement.